The value of pulmonary rehabilitation in patients with acute exacerbation of chronic obstructive pulmonary disease
10.11958/j.issn.0253-9896.2015.10.031
- VernacularTitle:急性加重期慢性阻塞性肺疾病患者肺康复治疗效果评价
- Author:
Hongyu QIAN
;
Yuzhen WANG
;
Yi LI
- Publication Type:Journal Article
- Keywords:
pulmonary disease,chronic obstructive;
pulmonary rehabilitation;
exacerbation;
6-minutes walk distance (6MWD);
COPD assessment test(CAT)
- From:
Tianjin Medical Journal
2015;(10):1201-1204
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effect of early pulmonary rehabilitation (PR) on patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods AECOPD patients (n=97) were randomly distributed into two groups:control group (n=39) and rehabilitation group (n=58). Patients in both groups were assessed when symptom im?proved from acute phase (baseline, T1). Then patients in control group only received pharmaco-therapy and rehabilitation ed?ucation without PR. When symptom was relieved and stable (T2), they were given 12 weeks PR (T3). On the other hand, pa?tients in rehabilitation group underwent a 12-week PR after T1 directly (T2). The lung function parameters, 6 min walking distance (6MWD), MRC scores and CAT scores were observed and analyzed in two groups. Results Until the end of the 12-weeks observation, the value of lung function showed no statistic differences between two groups(either T1 in control group vs T1 in PR group or T2 in PR group vs T2 and T3 in control group. In control group, the value of 6MWD scores of T3 was bet?ter than that of T1 and T2, in PR group(F6MWD=8.762,FMRC=4.432,FCAT=10.266,P<0.05)while MRC, CAT value in T3 of control group were higher than those in T1 and T2 of PR group. At T1, parameters does not demonstrate significant difference between these two groups. Value of 6MWD was higher while MRC and CAT were lower in T2 of PR group than that in T2 and T3 of control group. Conclusion Early pulmonary rehabilitation could improve the mobility and qulity of life, as well as ameliorate the severity of dyspnea in AECOPD patients.
